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Abstract. 
 
Expression of transforming Ha-Ras L61 in 
NIH3T3 cells causes profound morphological alter-
ations which include a disassembly of actin stress fibers. 
The Ras-induced dissolution of actin stress fibers is 
blocked by the specific PKC inhibitor GF109203X at 
concentrations which inhibit the activity of the atypical 
 
aPKC isotypes 
 
l
 
 and 
 
z
 
,
 
 whereas lower concentrations 
of the inhibitor which block conventional and novel 
PKC isotypes are ineffective. Coexpression of trans-
forming Ha-Ras L61 with kinase-defective, dominant-
negative (DN) mutants of aPKC-
 
l
 
 and aPKC-
 
z
 
,
 
 as well 
as antisense constructs encoding RNA-directed against 
isotype-specific 5
 
9
 
 sequences of the corresponding 
mRNA, abrogates the Ha-RasÐinduced reorganization 
of the actin cytoskeleton. Expression of a kinase-defec-
tive, DN mutant of cPKC-
 
a
 
 was unable to counteract 
Ras with regard to the dissolution of actin stress fibers. 
Transfection of cells with constructs encoding constitu-
tively active (CA) mutants of atypical aPKC-
 
l
 
 and 
aPKC-
 
z
 
 lead to a disassembly of stress fibers indepen-
dent of oncogenic Ha-Ras. Coexpression of (DN)
Rac-1 N17 and addition of the phosphatidylinositol
3
 
9
 
-kinase (PI3K) inhibitors wortmannin and LY294002 
are in agreement with a tentative model suggesting 
that, in the signaling pathway from Ha-Ras to the cy-
toskeleton aPKC-
 
l
 
 acts upstream of PI3K and Rac-1, 
whereas aPKC-
 
z
 
 functions downstream of PI3K and 
Rac-1.
This model is supported by studies demonstrating 
that cotransfection with plasmids encoding L61Ras and 
either aPKC-
 
l
 
 or aPKC-
 
z
 
 results in a stimulation of the 
kinase activity of both enzymes. Furthermore, the Ras-
mediated activation of PKC-
 
z
 
 was abrogated by coex-
pression of DN Rac-1 N17.
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E
 
XPRESSION
 
 of transforming Ha-Ras leads to pro-
found morphological alterations which include a
disassembly of F-actin stress fibers (Bar-Sagi and
Feramisco, 1986; Ridley and Hall, 1992; Prendergast and
Gibbs, 1993; Dartsch et al., 1994). Similar effects have
been described in Src-transformed cells (Felice et al., 1990;
Chang et al., 1995). Ras has been shown to induce changes
in cytoskeletal actin through members of the Rho family
(Ridley et al., 1992; Rodriguez-Viciana et al., 1994). This
family comprises the RhoA, RhoB, and RhoC proteins,
Rac-1 and Rac-2, TC10, two CDC42Hs proteins (also
known as G25K), RhoG (Hall, 1990; Shinjo et al., 1990;
Ridley and Hall, 1992; Ridley, 1995), and Rnd1 and Rnd-3/
RhoE (Nobes et al., 1998). Expression of a dominant-neg-
ative (DN)
 
1
 
 mutant of Rac-1 (Asn-17 Rac1) has been
shown to inhibit focus formation and tumorigenesis in-
duced by oncogenic Ras (Qui et al., 1995a,b; Prendergast et
al., 1995). Similar findings have been described after ex-
pression of a DN Asn-19 RhoB (Prendergast et al., 1995).
Expression of Asn-19 RhoB did not interfere with foci for-
mation by Raf-1, indicating that the Ras-RhoB pathway is
independent of Raf-1 (Prendergast et al., 1995). The com-
pound SCH 51344 has been described as a suppressor of
Ha-RasÐmediated transformation (Kumar et al., 1995) by
antagonizing the actin fiber reorganization without in-
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1. 
 
Abbreviations used in this paper: 
 
a, atypical; c, conventional; CA, consti-
tutively active;
 
 
 
DN, dominant-negative; GFP, green fluorescence protein;
n, novel; PI3K, phosphatidylinositol-3
 
9
 
 kinase; PKC, protein kinase C;
PVDF, polyvinylene difluoride.  
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terference with the growth factor-induced activation of
MEK, p44ERK1, or p90
 
RSK
 
 (Kumar et al., 1995). The data
obtained with the DN Rac and Rho mutants and SCH
51344 reverting transformation by Ras emphasize the sig-
nificance of the Ras-induced reorganization of the actin
cytoskeleton for the transformation by the oncogene.
The detailed molecular mechanism by which Ras af-
fects the actin cytoskeleton via Rac and Rho is still in-
sufficiently understood. Microinjection of recombinant,
activated RhoA induces actin stress fibers in the absence
of added growth factors (Paterson et al., 1990). Serum-
induced stress fiber formation can be blocked by the
 
Clostridium botulinum
 
 exoenzyme C3, an inhibitor of Rho
(Rubin et al., 1988; Aktories et al., 1989; Chardin et al.,
1989). Actin stress fibers are linked to integrins at the in-
ner surface of the plasma membrane through a multimo-
lecular protein complex called focal adhesion (Burridge et al.,
1988). Evidence for an implication of enzymes of the pro-
tein kinase C (PKC) family in focal adhesion formation
has been reported (Chun and Jacobson, 1992; Vuori
and Ruoslahti, 1993; Mogi et al., 1995). Activation of
PKC isoenzymes causes a stimulation of cell attachment,
spreading, and enhanced tyrosine phosphorylation of focal
adhesion kinase, pp125 FAK, a constituent of the focal ad-
hesion complex (Smith-Sinnett et al., 1993). FAK is ty-
rosine phosphorylated and its tyrosine kinase activity
enhanced upon integrin-mediated interaction with the ex-
tracellular matrix (Guan et al., 1991; Kornberg et al., 1992;
Zachary and Rozengurt, 1992). Enhanced tyrosine phos-
phorylation of FAK is also observed after exposure to sev-
eral growth factors (Burridge et al., 1992; Sinnett-Smith et
al., 1993; Rankin and Rozengurt, 1994). Thus, FAK may
represent a point of convergence where growth factor
induced signals meet signals from activated integrins
(Zachary and Rozengurt, 1992).
Stimulation of cells by some growth factors like platelet
derived growth factor (PDGF), epidermal growth factor
(EGF), or insulin has been shown to induce a reorganiza-
tion of actin filaments by mediating actin polymerization
at the plasma membrane, where actin filaments form a
compact meshwork resulting in the formation of mem-
brane ruffles and lamellipodia (Mellstrm et al., 1988; Rid-
ley and Hall, 1992; Rankin and Rozengurt, 1994). Actin
filament organization underlying membrane ruffles ap-
pears to be mediated by Rac as microinjection of a DN
Asn-17 Rac-1 inhibits PDGF-induced membrane ruffles,
whereas the constitutively active (CA) Val-12 Rac-1 induces
membrane ruffling and the formation of focal complexes
(Ridley and Hall, 1992; Qiu et al., 1995a,b). Evidence for
an implication of a LIM kinase catalyzed phosphorylation
of cofilin in Rac-mediated reorganization of actin cyto-
skeleton has been presented (Arber et al., 1998; Yang et
al., 1998). An additional form of actin filament organiza-
tion is found in microspikes and filopodia where small
bundles of actin filaments are attached to focal complexes
at the tips of the filopodia (Nobes and Hall, 1995). Actin
filament organization in filopodia appears to be regulated
by CDC 42Hs (Nobes and Hall, 1995).
CDC 42-, Rac-1-, and Rho-induced focal complexes are
morphologically distinct but share a variety of constituents
like vinculin, paxillin, and pp125 FAK
 
 
 
(Nobes and Hall,
1995). Evidence for a hierarchical relationship between
 
CDC 42, Rac and Rho, in which activation of CDC 42
leads to a sequential activation of Rac and Rho has been
presented (Nobes and Hall, 1995). The detailed mecha-
nisms, however, regulating the assembly and the spatial
organization of the different structures of actin filaments
are still insufficiently understood. In view of the similari-
ties between Rho- and Rac-induced focal complexes and
the well-documented implication of PKC in the assembly
of integrin-containing focal adhesions, a similar role of
representatives of the PKC family in the formation of Rac-
regulated focal complexes appears conceivable. An impli-
cation of enzymes of the PKC family in cytoskeleton orga-
nization is supported by a series of published observations
(for review see Keenan and Keleher, 1998). The interleu-
kin (IL)-2Ðmediated alteration of the cytoskeleton has re-
cently been demonstrated to require atypical aPKC-
 
z
 
 (Go-
mez et al., 1997). Transforming Ras has been shown to
activate PKC (Morris et al., 1989). Evidence for an impli-
cation of atypical aPKC-
 
l
 
 in the v-RasÐmediated activa-
tion and nuclear translocation of mitogen-activated pro-
tein kinase has been presented (Bjorkoy et al., 1997).
Induction of c-fos by oncogenic Ras has recently been
shown to require the coordinated activities of PKC-
 
l
 
, PKC-
 
e
 
,
and PKC-
 
z
 
 (Kampfer et al., 1998). However, whether the
Ras-mediated reorganization of the actin cytoskeleton is
PKC dependent, which PKC isotypes are involved, and
what their function in the Ras-mediated restructuring of
the cytoskeleton is, has remained unclear.
In this paper evidence is presented for an implication of
the two atypical PKC-
 
l
 
, and PKC-
 
z
 
 isotypes in the Ras-
mediated reorganization of the actin cytoskeleton. The
data support a tentative model for a signaling pathway in
which aPKC-
 
l
 
 acts downstream of Ras but upstream of
phosphatidylinositol-3
 
9
 
 kinase (PI3K) and Rac-1, whereas
aPKC-
 
z
 
 functions downstream of Rac-1.
 
Materials and Methods
 
Reagents and Plasmids
 
DulbeccoÕs modified EagleÕs medium (DME) and restriction enzymes for
molecular biological approaches were purchased from Boehringer Mann-
heim. Fetal calf serum and 
 
L
 
-glutamine were obtained from BioWhittaker.
Leupeptin, myelin basic protein (M-1891), tetramethylrhodamine-isothio-
cyanate (TRITC)-labeled phalloidin, and aprotinin are products from
Sigma. Lipofectin transfection reagents and Opti-Mem I medium were
purchased from Life Technologies. [
 
g
 
-
 
32
 
P]ATP (10 mCi/ml, 3000 Ci/
mmol) and Hyperfilm-MP were obtained from Amersham. PCR primers
used for subcloning strategy were obtained from ARK Scientific.
Subcloning strategy and oligonucleotides used for antisense constructs
had been described elsewhere (Kampfer et al., 1998). Orientation of inser-
tion was determined by restriction analysis and sequencing. Subcloning
strategy, mutagenic primers, as well as selection primers for the genera-
tion of kinase-defective, DN, as well as CA mutants of PKC isotypes had
been described elsewhere (Baier-Bitterlich et al., 1996; berall et al.,
1997; Kampfer et al., 1998). All cDNAs for PKC isotypes, green fluores-
cence protein (GFP), and the cDNA for Rac-1 N17 were subcloned into
the expression vector pEF-1neo. GF109203X, LY294002, wortmannin,
and Pansorbin beads were obtained from Calbiochem-Novabiochem.
 
Cell Culture and Transient Transfection Procedures
 
NIH3T3 fibroblasts were kept at logarithmic growth phase in DME sup-
plemented with 10% heat-inactivated fetal calf serum, lysophosphatidic
acid (100 ng/ml), and 2 mM 
 
L
 
-glutamine in a humidified atmosphere con-
taining 5% CO
 
2
 
. To obtain transient transfectants, NIH3T3 cells (5 
 
3 
 
10
 
4
 
cells per well) were seeded in 100-mm-diam wells containing circular glass 
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coverslips (eight per well) and were transfected for 8 h with 1 
 
m
 
g pEF-
1neoGFP expression plasmid, 1.5 
 
m
 
g pSR-
 
a
 
II L61 Ha-Ras (encoding a
constitutively active Ras leucine L61 mutant), and 20 
 
m
 
g of plasmids
encoding for kinase-defective, DN cPKC-
 
a
 
 K368R, atypical aPKC-
 
l
 
K275W, and aPKC-
 
z
 
 K275W mutants. Alternatively, NIH3T3 fibroblasts
were cotransfected with plasmids encoding pEF-1neoGFP plus a CA
aPKC-
 
l
 
 A119E, (CA) aPKC-
 
z
 
 A119E, and (CA) cPKC-
 
a
 
 A25E mutants,
or vector controls (pEF-1neo), respectively.
 
Fluorescence Imaging
 
48 h after the transfection procedure cells were washed twice with PBS
(140 mM NaCl, 2.7 mM KCl, 4.6 mM Na
 
2
 
HPO
 
4
 
 
 
? 
 
12 H
 
2
 
O, 1.3 mM
NaH
 
2
 
PO
 
4
 
 
 
? 
 
H
 
2
 
O), fixed with 3.5% formaldehyde (wt/vol in PBS, 10 min)
at room temperature and after extensive washing, permeabilized for 5 min
with ice-cold acetone. After permeabilizing, the coverslips were washed
twice with PBS and incubated for 1 h with FACS
 
¨
 
 buffer (500 ml PBS, 1 g
sodium azid, and 4% fetal calf serum). For visualizing the F-actin struc-
ture, assembly cells fixed onto glass coverslips were overlaid with 100 
 
m
 
l
(0.1 g/ml) TRITC-conjugated phalloidin per coverslip for 1 h. Afterwards
the stained cells were washed six times with PBS and with distilled water
and mounted in Mowiol containing 0.1% (wt/vol) 
 
p
 
-phenylenediamine.
Mounted cells were viewed on an Olympus BX50 fluorescence micro-
scope, and images of green fluorescence-positive cells were done by using
a RGB-mode video real-color camera (Optronics Engineering DEI-470).
Image processing was carried out with the image processing software
MetaMorph (Princeton Instruments). The green and red fluorescence im-
ages were recorded separately by changing the excitation wavelength
(from 480 to 550 nm), exported into Adobe Photoshop, and then printed
on a color laser copier system (Agfa 707).
 
Measurement of Total F-actin Fiber Length
 
Total F-actin fiber length was calculated after digitalizing TRITC-phalloi-
din stained F-actin by using the MetaMorph image processing software.
The edges of the cells were detected by the aid of a convolution kernel
comparing the brightness of the neighboring pixels. After thresholding
and separating from the background specimen, fiber lengths were deter-
mined and expressed as the percentage of the mean fiber length compared
with the fiber length of mock-transfected fibroblasts.
 
Partial Purification of 6
 
3
 
 His-tagged PKC Isotypes and 
PKC In Vitro Assays
 
African green monkey kidney fibroblasts (COS-1, 10
 
6
 
/100-mm dish) were
transfected with 15 
 
m
 
g of circular plasmid DNA per dish by lipofectin re-
agents, as described by the manufacturer. 48 h posttransfection, cells were
lysed in 1 ml lysis buffer (150 mM NaCl, 20 mM 
 
N
 
-2-hydroxyethylpipera-
zine-
 
N
 
9
 
-2-ethanesulfonic acid [HEPES, pH 7.59], 1% Nonidet P-40 (vol/
vol), 50 
 
m
 
g/ml each aprotinin and leupeptin, and 1 mM phenyl-methylsul-
fonyl fluoride). Lysates were purified by using a Ni
 
2
 
1
 
-resin batch proce-
dure, and equal amounts of recombinant PKC isotypes were subjected to
an enzymatic PKC assay as described elsewhere (Baier-Bitterlich et al.,
1996; berall et al., 1997; Kampfer et al., 1998). Enzyme activities of re-
combinant PKC-isotypes 
 
a
 
, 
 
l
 
, and 
 
z
 
 are expressed as cofactor-dependent
phosphorylation of the [A25S] synthetic PKC peptide (RFARKGSL-
RQKNVY; presenting the pseudosubstrate sequence of PKC-
 
a
 
 with an
alanine to serine substitution). The concentrations of substrate peptide
and cofactors used are: 50 
 
m
 
g/ml [A25S], 280 
 
m
 
g/ml PtdSer, 10 
 
m
 
M TPA,
and 1 mM CaCl
 
2
 
. Expression of the fusion tag peptide COOH-terminal of
PKC-
 
a
 
 and PKC-
 
l
 
 and PKC-
 
z
 
 did not affect the kinase activity in vitro
(berall et al., 1997).
 
Magnetic Separation of Transient Transfected COS-1 
Cells and PKC-
 
z
 
 Immunocomplex Kinase Assay 
 
COS-1 cells cotransfected with pMACS4 (Miltenyi Biotech, 1.5 
 
m
 
g), and
therefore expressing a truncated CD4 surface marker, were washed twice
with PBS and then incubated with PBE (PBS with 5 mM EDTA and 0.5%
skimmed milk powder) for 10 min at 37
 
8
 
C to detach cells from the cell cul-
ture dish. Suspended cells were incubated for 45 min, 4
 
8
 
C with MACS4
magnetic microbeads (diluted 1:10 in PBE) at 4
 
8
 
C and the positive-trans-
fected cells were separated from the nontransfected background over
magnetic columns. Magnetically separated COS-1 cells were washed with
cold PBS and lysed on ice in 500 
 
m
 
l of lysis buffer A (50 mM Tris-HCl, pH
 
7.3, 50 mM NaCl, 5 mM Na
 
4
 
P
 
2
 
O
 
7 
 
? 
 
10 H
 
2
 
O (NaPP), 5 mM EDTA, 2%
Nonidet P-40, 25 
 
m
 
g/ml leupeptin, 25 
 
m
 
g/ml aprotinin, 50 mM NaF, and
100 mM Na
 
3
 
VO
 
4
 
) for 10 min and lysates clarified by centrifugation at
10,000 
 
g 
 
for 5 min 4
 
8
 
C.
Aliquots of cell equivalents containing equal amounts of protein were
subjected to an immunoprecipitation (IP) procedure using a correspond-
ing PKC-
 
z
 
 antibody purchased from Santa Cruz Biotechnology. IPs were
recovered by using Pansorbin beads. PKC-
 
z
 
 molecules bound to 35 
 
m
 
l of
Pansorbin beads, were resuspended in 20 
 
m
 
l kinase buffer, and then mixed
with 9 
 
m
 
g myelin basic protein (Sigma M-1891). The kinase reactions were
initiated by the addition of 2 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP (10 mCi/ml, 3,000 Ci/mmol)
and incubation of the tubes by frequent vortexing at 30
 
8
 
C for 30 min.
Phosphorylation of myelin basic protein was terminated by the addition of
5 
 
m
 
l of 5
 
3 
 
SDS sample buffer and boiling the samples for 5 min. Probes
were analyzed by SDS-PAGE (10%) and transferred to polyvinylene di-
fluoride (PVDF) membranes (Millipore). Computer-assisted calculation
of PKC-
 
z
 
 enzyme activities was done after scanning the corresponding
PVDF membranes by using the Scanner Controller Sci System.
 
Results
 
The Reorganization of Actin Cytoskeleton Induced by 
Transforming Ras Is Antagonized by the Specific PKC 
Inhibitor GF109203X
 
NIH3T3 cells transiently transfected with the transforming
Ha-Ras L61 oncogene exhibit dramatic morphological dif-
ferences compared with their nontransfected counterparts.
Normal NIH3T3 fibroblasts are spreading on the extracel-
lular matrix, appear flat, and exhibit bundles of actin stress
fibers traversing the cell (Fig. 1 A). Cells expressing the
Ras oncogene are more spindle-shaped, exhibit frequently
long protrusions, and are characteristically devoid of actin
stress fibers (Fig. 1 B). Similar morphological effects of
transforming Ras have been described by other authors
(Bar-Sagi and Feramisco, 1986; Ridley and Hall, 1992;
Prendergast and Gibbs, 1993; Dartsch et al., 1994; Rod-
riguez-Viciana et al., 1994).
As shown in Fig. 1 D, the PKC-specific inhibitor
GF109203X (Toullec et al., 1991) is capable of reversing
the dissolution of actin stress fibers by Ras. This effect is
observed in the presence of 6 
 
m
 
M of the inhibitor (Fig. 1
D). 200 nM of the compound which had been shown to be
sufficient for blocking c- and n-type PKC isotype kinase
activity in cell-free extracts (Fig. 2 A) (berall et al.,
1997), is, however, without an effect on the Ras-mediated
stress fiber dissolution (Fig. 1 C). 6 
 
m
 
M GF109203X corre-
sponds roughly to the IC
 
50 
 
of the compound against the
atypical PKC-
 
z
 
 (Fig. 2 B, see also Martiny-Baron et al.,
1993), and as shown in Fig. 2 C, exerts a similar effect on
PKC-
 
l
 
, suggesting that if a PKC is involved in the Ras-
induced reorganization of the actin cytoskeleton, it should
be an atypical (a-), rather than a conventional (c-) or novel
(n-) type PKC isoform.
 
Reversion of Ras-induced Alteration of Actin 
Cytoskeleton by Kinase-defective, DN Mutants of 
Atypical PKC-
 
l
 
, and PKC-
 
z
 
 as well as by PKC-
 
l
 
Ð and 
PKC-
 
z
 
Ðspecific Antisense Constructs
As shown in Fig. 3, B and D, expression of aPKC-l
K275W as well as PKC-z K275W mutants, which contain
an inactive ATP-binding site, is able to revert the Ras-
induced depolymerization of actin stress fibers. For these
experiments NIH3T3 cells were transiently cotransfected
with vectors encoding Ha-Ras L61 and kinase-defective,The Journal of Cell Biology, Volume 144, 1999 416
DN aPKC-l K275W or aPKC-z K275W mutants, respec-
tively, using a green fluorescence protein expression vec-
tor as a transfection marker. Ras-induced reorganization
of F-actin cytoskeleton was not affected by an expression
of a kinase-defective, DN mutant of PKC-a K368R (Fig. 3
F). Expression levels of cPKC-a K368R, aPKC-l K275R,
and aPKC-z K275R were found to be in a similar range
(data not shown).
The effects observed after expression of the DN ver-
sions of PKC-l and PKC-z were checked by PKC-lÐ and
PKC-z-specific antisense constructs. For this purpose,
cells were transfected with constructs encoding isotype-
specific 59 sequences targeted to the corresponding mRNA.
As described previously, generation of these antisense
RNA sequences leads to an almost complete depletion of
the endogenous aPKC-l and -z (Kampfer et al., 1998).
Fig. 3, C and E demonstrate that isotype-specific deple-
tion of aPKC-l and aPKC-z yields the same results as ex-
pression of DN mutants of these isotypes. In agreement
with the results obtained with the DN PKC-a mutant,
PKC-a antisense did not affect the Ras-mediated alter-
ations of F-actin organization (Fig. 3 G). Neither cPKC-a
nor aPKC-l/-z sense constructs did affect the Ras-medi-
ated disassembly of F-actin fibers (data not shown).
A quantitative evaluation of Ras-mediated stress fi-
ber depolymerization and the effects of (DN) aPKC-l
K275W, (DN) aPKC-z K275W, aPKC-l, and aPKC-z anti-
sense on Ras-induced actin fiber organization was per-
formed by measuring F-actin fiber length with the aid of the
MetaMorph image processing software (Fig. 4, A and B).
The data shown in Figs. 3 and 4 clearly indicate that the
Ras-mediated alteration of actin cytoskeleton is antago-
nized by an isotype-specific inhibition or depletion of
aPKC-l and aPKC-z. These findings strongly suggest that
the Ras-mediated reorganization of the actin cytoskeleton
is mediated by these two atypical aPKC isotypes.
Expression of CA Mutants of Atypical aPKC-l and 
aPKC-z Mimic the Effect of Transforming Ras L61 on 
Actin Cytoskeleton
It has previously been demonstrated that substitution of
an alanine by a glutamate within the pseudosubstrate do-
main of PKC isotypes generates CA mutants with reduced
cofactor requirements. Biochemical and biological proper-
ties of these mutants had been described in preceding pub-
lications (Baier-Bitterlich et al., 1996; berall et al., 1997;
Kampfer et al., 1998).
If Ha-Ras uses atypical PKC isotypes for the reorganiza-
tion of the actin cytoskeleton as suggested by the data
shown in Figs. 3 and 4, expression of CA aPKC-l and
(CA) aPKC-z mutants should affect actin stress fibers like
transforming Ha-Ras. As shown in Fig. 5, B and D, this is
indeed the case. A CA mutant of PKC-a A25E did not
show any significant effect on stress fiber rearrangements
(data not shown).
Stress fibers reappear after treatment of the aPKC-l
A119E- or aPKC-z A119E-expressing cells with the PKC
inhibitor GF109203X demonstrating that the alterations of
the actin cytoskeleton in cells expressing the constitutively
active versions of these atypical PKC isotypes are indeed
caused by a PKC activity (Fig. 5, C and E).
Evidence That Atypical aPKC-l Acts Upstream and 
aPKC-z Acts Downstream of Rac-1
An early event after expression of oncogenic Ras is the
generation of membrane ruffles and a reorganization of
the actin cytoskeleton, i.e., stress fibers disappear whereas
F-actin accumulates at the cell periphery (Bar-Sagi and
Feramisco, 1986; Ridley et al., 1992; Rodriguez-Viciana et al.,
1994). Evidence for an implication of Rac-1 in Ras-medi-
ated reorganization of the actin cytoskeleton has been pre-
Figure 1. Ras L61-induced F-actin stress fiber disassembly is an-
tagonized by the specific PKC inhibitor GF109203X at concen-
trations sensitive for atypical PKC-isotypes. Representative fluo-
rescence images of green fluorescence protein expressing (top
panels) versus TRITC-phalloidinÐstained fibroblasts (bottom
panels), transiently expressing Ha-Ras L61 (BÐD). (A) Vector
control; (B) Ras L61; (C) Ras L61 in the presence of 200 nM
GF109203X; (D) Ras L61 in the presence of 6 mM GF109203X.
48 h posttransfection, cells were fixed and expression of GFP was
visualized by fluorescence microscopy. F-actin filaments were
stained by using TRITC-conjugated phalloidin. Representative
cells of at least three different experiments are shown for all pan-
els. Stacks of images were exported into Adobe Photoshop and
printed as described in Materials and Methods. Bar, 10 mm.berall et al. PKC in Ras-mediated Reorganization of Actin Cytoskeleton 417
sented (Ridley et al., 1992; Rodriguez-Viciana et al., 1994).
The data described so far suggest that the atypical PKC
isotypes l and z are also involved in this process. It ap-
peared interesting, therefore, to investigate whether they
act within the Ras/Rac pathway and if they do, whether
their position within this pathway can be identified.
As should be expected, DN N17 Rac-1 inhibits the Ras-
mediated disassembly of stress fibers (Fig. 6, A and B). To
obtain some information whether PKC-l and PKC-z
cooperate with Rac-1 in the same pathway, cells were
cotransfected with combinations of either CA aPKC-l
A119E and N17 Rac-1 or CA aPKC-z A119E and N17
Rac-1.
As shown in Fig. 6 C, N17 Rac-1 is able to overcome
stress fiber disassembly induced by CA aPKC-l A119E
(compare with Fig. 5 for the effect of aPKC-l A119E in
the absence of N17 Rac-1), indicating that aPKC-l acts
upstream of Rac-1. Stress fiber disassembly by aPKC-z
A119E, however, is not affected by N17 Rac-1 (Fig. 6 D),
suggesting that aPKC-z acts either downstream or inde-
pendent of Rac-1. A quantitative evaluation of the stress
fiber alterations shown in Fig. 6 is presented in Fig. 4 B
and Fig. 10.
Effects of Transforming Ras and CA Rac on aPKC-l 
and aPKC-z
The data presented so far suggest that Ras mediates the
effects on the cytoskeleton via a pathway containing
aPKC-lÐRac-1 and aPKC-z. If this model is correct, Ras
should activate aPKC-l and aPKC-z whereas Rac should
be able to stimulate aPKC-z. Unfortunately, this question
could not be addressed in NIH3T3 cells due to the low
transfection efficiencies in this cell type. Therefore, these
studies were performed with COS cells. As shown in Fig. 7
A, cotransfection of COS cells with plasmids encoding
Ras L61 and 63 His-tagged aPKC-l leads to a significant
activation of the kinase activity of aPKC-l. Coexpression
of Ras L61 and aPKC-z results in a marked stimulation
of aPKC-z as demonstrated in Fig. 7 B. Furthermore, co-
transfection of a plasmid encoding CA V12Rac with a con-
struct encoding aPKC-z also revealed an activation of
Figure 2. Effect of GF109203X on cPKC-a, aPKC-z, and aPKC-l enzyme activities.
COS-1 fibroblasts were transiently transfected with 15 mg of PKC-a, PKC-l, and PKC-z
constructs encoding for wild-type PKC using the lipofectin technique as described by
the manufacturer. Enzyme activities are expressed as cofactor-dependent phosphory-
lation of the synthetic PKC peptide [A25S], in the absence or presence of various con-
centrations of GF109203X. The concentrations of synthetic substrates and cofactors
used are: 50 mg/ml [A25S] (synthetic peptide RFARKGSLRQKNVY representing the
pseudosubstrate sequence of PKC-a with a alanine-to-serine substitution), 280 mg/ml
PtdSer, 10 mM TPA, and 1 mM CaCl2. Expression of the fusion tag-peptide COOH-
terminal of the recombinant PKC-isotypes was found not to affect the kinase activity
in vitro (berall et al., 1997). Shown are kinase activities of Ni21-batched recombinant
cPKC-a, atypical aPKC-z, and atypical aPKC-l. (AÐC) GF109203X, at the concentra-
tions described above, was present for 15 min during the whole PKC assay running
time. Data are expressed as percent of stimulated controls (6 SEM) of at least three
independent experiments done in triplicate.The Journal of Cell Biology, Volume 144, 1999 418
aPKC-z by Rac (Fig. 7 C). Surprisingly, V12Rac in addi-
tion to aPKC-z also activated aPKC-l (data not shown).
However, this finding is not in conflict with data or models
presented so far. Possible interpretations for this effect
will be presented in the Discussion. Our conclusion that
Ras activates aPKC-z by a Rac-1Ðdependent mechanism is
supported by the fact that expression of DN N17Rac
blocks Ras-mediated stimulation of aPKC-z (Fig. 7 D).
N17Rac does not inhibit Ras-mediated activation of PKC-l
(data not shown).
Figure 3. Reversion of Ras-induced disassembly of F-actin cy-
toskeleton by kinase-defective, DN as well as PKC isotype-spe-
cific antisense constructs. Shown are representative fluorescence
images of fibroblasts transiently expressing Ha-Ras L61 (AÐG).
(A) Ha-Ras L61 alone, or (B) together with DN aPKC-l; (C)
antisense aPKC-l; (D) DN aPKC-z; (E) antisense aPKC-z; (F)
DN cPKC-a; and (G) antisense cPKC-a. 48 h posttransfection,
cells were fixed and visualized as described in Materials and
Methods. Representative cells of at least three different experi-
ments are shown for all panels. The corresponding sense con-
structs were analyzed in parallel (data not shown). Stacks of im-
ages were exported into Adobe Photoshop and printed on a
color laser copier system.berall et al. PKC in Ras-mediated Reorganization of Actin Cytoskeleton 419
Effect of PI3K Inhibitors on Actin Cytoskeleton 
Reorganization Induced by Oncogenic Ras or CA 
Mutants of aPKC-l and aPKC-z
PI3K has been shown to be implicated in the Ras-induced
reorganization of actin cytoskeleton (Rodriguez-Viciana
et al., 1994). In agreement with these findings, treatment
of Ras-expressing cells with the PI3K inhibitors wortman-
nin or LY294002 counteracts the effects of Ras on the ac-
tin cytoskeleton (Fig. 8). Both inhibitors also antagonize
the disassembly of actin stress fibers induced by constitu-
tively active aPKC-l A119E, whereas the cytoskeletal re-
organization mediated by the aPKC-z A119E mutant was
not affected (Fig. 9). These data suggest that aPKC-l acts
upstream of PI3K whereas aPKC-z functions either down-
stream or independent of PI3K. A quantitative evaluation
of the effects of the PI3K inhibitors is presented in Fig. 4 B
and Fig. 10.
Discussion
The data presented here demonstrate that transforming
Ha-Ras uses atypical aPKC-l and aPKC-z for the rear-
rangement of actin cytoskeleton. This conclusion is based
on the observation that (a) the Ha-RasÐinduced dissolu-
tion of actin stress fibers is blocked by the specific PKC in-
hibitor GF109203X at concentrations which inhibit the
activity of the atypical aPKC isotypes l and z. (b) Coex-
pression of transforming Ha-Ras L61 with kinase-defec-
tive, DN mutants of aPKC-l and aPKC-z, as well as
antisense constructs encoding RNA directed against iso-
type-specific 59 sequences of the corresponding mRNAs,
abrogate the Ha-RasÐinduced reorganization of the actin
cytoskeleton. (c) Finally, transfection of cells with con-
structs encoding CA mutants of atypical aPKC-l and
aPKC-z mimic the effect of oncogenic Ha-Ras on actin cy-
toskeleton reorganization.
With regard to the effects of the PKC inhibitor
GF109203X, it may appear surprising that concentrations
of the inhibitor which, in vitro, reduce the activity of
aPKC-l and aPKC-z to z50% cause an almost complete
reversal of the Ras-mediated disassembly of F-actin stress
fibers. It should be emphasized, however, that neither the
biological activators nor the intracellular substrates of
atypical PKC isozymes have been sufficiently identified.
Thus, the reaction mixtures used for the determination of
the enzyme activity of the two kinases certainly differ from
the in vivo conditions and this may affect the sensitivity to
the inhibitor. Furthermore, both aPKC-l and aPKC-z are
affected by the inhibitor to about the same extent, i.e.,
z50%. Since both enzymes are required for the Ras-medi-
ated restructuring of actin cytoskeleton, the simultaneous
inhibition of both enzymes may result in an additive effect.
Finally, the intracellular concentration of the inhibitor is
not known. It is possible, therefore, that locally higher
concentrations than 6 mM have been achieved.
Expression of a kinase-defective, DN mutant of PKC-a
or PKC-a depletion by intracellular generation of PKC-a
antisense RNA did not affect the Ras-induced alterations
of the actin cytoskeleton. In a previous paper we had
demonstrated that the phosphorylation of MARCKS in
NIH3T3 cells under biological conditions is mediated by
PKC-a and that the phorbol ester-induced phosphoryla-
tion of MARCKS is markedly inhibited by expression of
the kinase-defective, DN PKC-a K368R mutant (berall
et al., 1997). Thus, the inability of PKC-a K368R to inter-
fere with the Ras-induced effects on actin cytoskeleton is
not explained by an insufficient intracellular expression
level. Furthermore, the phosphorylation of MARCKS,
which has been discussed as an important regulator of ac-
tin organization (Rosen et al., 1990), does not appear to be
involved in the Ras-induced reorganization of the actin cy-
toskeleton.
The Ras-induced reorganization of actin cytoskeleton
Figure 4. Quantitative evalu-
ation of total fiber length. Ef-
fects of kinase-defective, DN
PKC-isotypes. Total F-actin
fiber length was calculated
after digitalizing TRITC-
phalloidin stained F-actin by
using the MetaMorph image
processing software S/N
3542A. The edges of the cells
were detected by the aid of a
convolution kernel. This
means that the brightness of
the neighboring pixels were
compared. After threshold-
ing and separating from the
background specimen, fiber
lengths were calculated and
expressed as the means of to-
tal fiber length compared
with the fiber length of mock-transfected fibroblasts. Shown are morphological alterations of Ras-mediated stress fiber disassembly un-
der the influence of (A) (DN) aPKC-l K275W, antisense aPKC-l, (DN) aPKC-z, antisense aPKC-z, and (B), (DN) N17 Rac-1, and the
PI3K inhibitors wortmannin and LY294002. Bars indicate means (6 SEM) of at least three independent experiments with z60Ð75
GFP-positive cells which were separately analyzed per coverslip.The Journal of Cell Biology, Volume 144, 1999 420
has been shown to be mediated by Rac-1 and PI3K (Jone-
son and Bar-Sagi, 1997). The data presented here suggest
that aPKC-l acts upstream of PI3K and Rac-1, whereas
aPKC-z functions either downstream or independent of
Rac-1. This conclusion is based on the following findings:
(a) the effects of the constitutively active mutant of aPKC-l
which mimics Ras with regard to the alterations of actin
cytoskeleton are inhibited by the PI3K blockers wortman-
nin and LY294002 and also by expression of DN N17 Rac-1;
and (b) expression of N17 Rac-1 does not interfere with
the disassembly of actin stress fibers induced by the CA
aPKC-z A119E mutant. The sequence Ras-aPKC-lÐPI3K-
Rac-1 would be in accordance with the model suggested
by Rodriguez-Viciana et al. (1994), who propose a path-
way in which the Ras-mediated activation of Rac-1 is me-
diated by PI3K. Our findings would add atypical aPKC-l
as an upstream element of this sequence, a model consis-
tent with data demonstrating a physical interaction of
aPKC-l with p21ras (Diaz-Meco et al., 1994).
The studies presented here demonstrate that in intact
cells, Ras is capable of activating aPKC-l. Furthermore,
it is shown here that in addition to the stimulation of
aPKC-l, Ras also enhances the kinase activity of aPKC-z.
The latter effect is suppressed in cells expressing DN
N17Rac. We conclude, therefore, that Ras activates
aPKC-z by a Rac-1Ðdependent mechanism. This conclu-
sion is supported by the finding that expression of consti-
tutively active V12Rac enhances the kinase activity of
aPKC-z. Surprisingly, V12Rac was also found to be capa-
ble of activating aPKC-l. However, this observation is not
in conflict with the other data presented in this paper, and
does also not contradict a model suggesting that the effects
of Ras on actin cytoskeleton are mediated by a pathway
comprising aPKC-lÐRac-aPKC-z. The fact that in COS
cells V12Rac can activate aPKC-l indicates that an activa-
tion of Rac-1 by a Ras-independent pathway, e.g., via
CDC 42, may lead to a Rac-mediated activation of aPKC-l
and aPKC-z. This is obviously in contrast to the pathway
activated by oncogenic Ras where aPKC-l acts upstream
and aPKC-z downstream of Rac as outlined above. A con-
clusion which is also supported by the observation that in
COS cells DN N17Rac does not interfere with Ras-medi-
ated activation of aPKC-l.
As the mechanism by which Ras affects actin filament
Figure 5. CA PKC mutants mimic the Ras-mediated disassem-
bly of F-actin. Potency of the PKC-specific inhibitor GF109203X
to revert the disassembly of actin fibers induced by CA mutants.
Shown are representative fluorescence images of fibroblasts
transiently expressing constitutively active (CA) PKC mutants
alone (B and D), or in the presence of 6 mM GF109203X (C and
E). (A) Control, (B) (CA) atypical aPKC-l A119E; (C) plus
GF109203X; (D) (CA) aPKC-z A119E; (E) plus GF109203X.
48 h posttransfection, cells were fixed and visualized as de-
scribed in Materials and Methods. Representative cells of at
least three different experiments are shown for all panels. Stacks
of images were exported into Adobe Photoshop and printed as
described above.berall et al. PKC in Ras-mediated Reorganization of Actin Cytoskeleton 421
structures are incompletely understood, it can be only
speculated with regard to the function of aPKC-l or
aPKC-z in this pathway. The disassembly of actin stress fi-
bers has been correlated to the accumulation of inactive,
GDP-charged RhoA (Qui et al., 1995a,b). Activation of
RhoA by an exchange of the GDP by a GTP was found to
stimulate stress fiber formation (Ridley and Hall, 1992).
These findings suggest that the Ras-induced disassembly
of actin stress fibers is the result of a conversion of the ac-
tive, GTP-charged Rho to the inactive GDP-bound form.
Models for a biochemical linkage between the Ras and
Rho proteins have been proposed (Boguski et al., 1992;
Nobes and Hall, 1994; Chant and Stowers, 1995). In one
simple model, the Ras/Rho pathway includes p120GAP,
the Ras GTPase-activating protein which may also act as
a Ras effector (Chant and Stowers, 1995) and p190, a
p120GAP-associated protein which exhibits a Rho-specific
Figure 6. Evidence that atypical aPKC-l acts upstream and
aPKC-z acts downstream of Rac-1. Shown are representative flu-
orescence images of fibroblasts transiently expressing Ha-Ras
L61 (A and B). (A) Ha-Ras L61 alone, or (B) together with
DN Rac-1 N17; (C) (CA) aPKC-l A119E together with (DN)
Rac-1 N17; or (D) (CA) aPKC-z A119E together with (DN)
Rac-1 N17. 48 h posttransfection, cells were fixed and visualized
as described in Materials and Methods. Representative cells of at
least three different experiments are shown for all panels. Stacks
of images were exported into Adobe Photoshop and printed on a
color laser copier system.
Figure 7. Effects of oncogenic Ras and constitutively active Rac
on kinase activities of aPKC-z and aPKC-l. Shown are represen-
tative immunocomplex kinases assays (BÐD) and an in vitro ki-
nase assay (A) of magnetically separated COS-1 cells. The data
are designed as bar graphs (top panels) and as corresponding au-
toradiograms of the myelin basic protein (MBP) assay (bottom
panels). Equal amounts of recombinant proteins used in the ex-
periment were employed using a standard Western blotting
technique as described by Kampfer et al. (1998). In brief, loga-
rithmically growing cells were transiently cotransfected with (A)
Ha-Ras L61 together with aPKC-l/i, (B) Ha-Ras L61 together
with aPKC-z, (C) CA Rac-1 V12 together with aPKC-z, and (D)
DN Rac-1 N17 together with aPKC-z. Concerning magnetic bead
separation of positively transfected cells, a truncated CD4 sur-
face marker was cotransfected in B and C. 48 h posttransfection,
cells were separated by using magnetic beads as described by the
manufacturer and PKC assays were done as described under Ma-
terials and Methods. Enzyme activities are expressed as cofactor-
independent phosphorylation of (A) a synthetic PKC-a peptide
(A25S, for details see Fig. 2 legend) or myelin basic protein
(BÐD). Computer-assisted calculation of PKC-z or PKC-l activi-
ties were done after scanning the corresponding PVDF mem-
branes by using the Scanner Controller Sci System.The Journal of Cell Biology, Volume 144, 1999 422
GTPase-activating domain (Settleman et al., 1992; Foster
et al., 1994). Phosphorylation by aPKC-l and/or aPKC-z
may enhance the activity of p190Rho-GAP, resulting in an in-
creased conversion of RhoGTP to RhoGDP and stress fi-
ber dissolution. Tyrosine phosphorylation of p190 by c-Src
has been shown to be correlated with EGF-induced stress
fiber disassembly (Chang et al., 1995). Evidence for a
PKC-catalyzed serine/threonine phosphorylation of p190,
however, is still lacking. Alternatively, aPKC-l and/or
aPKC-z may enhance the RhoGDP level by inhibiting
Rho-GDI, or exchange factors (GEF) acting on Rho, like
SmgGDS, Rap1, Dbl, Ect2, and Ost (Hiraoka et al., 1992;
Miki et al., 1993; Horii et al., 1994). However, models in
which the Ras-induced disassembly of actin stress fibers
are described as resulting exclusively from a Ras-mediated
conversion of RhoGTP to RhoGDP are inconsistent with
the findings demonstrating an activation of Rho by Ras as
essential for transformation and mitogenesis by oncogenic
Ras (Prendergast et al., 1995; Qui et al., 1995a,b; Olson et
al., 1998).
CA mutants of Rac1 and RhoA enhance the transform-
ing activity of Ras including the oncogene-induced mor-
phological alterations (Khosravi-Far et al., 1995).The
biological meaning of the reorganization of the actin cy-
toskeleton by transforming Ras as well as the role of
RhoA in Ras transformed cells are not quite clear. As out-
lined above, activation of RhoA is required for transfor-
mation by Ras and expression of a CA mutant of RhoA
enhances the transforming activity of Ras (Khosravi-Far
et al., 1995). The fact, however, that oncogenic Ras causes
a disassembly of actin stress fibers whereas CA RhoA pro-
motes stress fiber formation indicates that oncogenic Ras
somehow deregulates the normal Rho-mediated effects on
the cytoskeleton. In Ras-transformed cells, the activation
of Rho has been shown to be required for a suppression of
p21Waf1/Kip which is upregulated in cells expressing on-
cogenic Ras (Olson et al., 1998), thus indicating that Rho
exerts other functions besides regulation of the actin cy-
toskeleton. This notion is supported by findings indicating
that RhoA can mediate several distinct effector pathways
and that transformation by RhoA and the ability to re-
model the cytoskeleton are, to some extent, independent,
e.g., transformation was found to correlate with Rho-asso-
ciated kinase binding rather than stress fiber formation
(Sahai et al., 1998). Thus, the Ras-mediated disassembly of
actin stress fibers is not necessarily in conflict with the pos-
tulated activation of RhoA in Ras-transformed cells. Fur-
thermore, expression of the Rho family member Rnd3/
RhoE has been shown to result in a phenotype which
strikingly resembles the phenotypic alterations caused by
oncogenic Ras, i.e., cell rounding, loss of stress fibers, and
decreased cell adhesion (Nobes et al., 1998). Recent re-
sults suggest that RhoE may act to inhibit signaling down-
stream of RhoA, by altering some RhoA-regulated re-
sponses, such as stress fiber formation, whereas other
RhoA-mediated effects remain unaffected (Guasch et al.,
1998).
The biochemical function of aPKC-l and aPKC-z in the
Ras/Rac/Rho pathway remains to be elucidated. Evidence
for PKC as an important regulator of cytoskeletal func-
tions has been presented by numerous studies (Keenan
and Kelleher, 1998). Stress fibers are associated with focal
adhesion complexes where cells interact with the extracel-
lular matrix. The interaction with the extracellular matrix
is mediated by integrin receptors which are integral com-
ponents of focal adhesion plaques (Schwartz et al., 1995).
Activation of integrin receptors initiates a signaling cas-
cade which has been shown to depend on stress fibers
(Hynes, 1992; Rosales et al., 1995; Wu et al., 1995) and to
cooperate with growth factor-mediated events (Clark and
Brugge, 1995; Schwartz et al., 1995). An implication of
PKC in focal adhesion formation and integrin-mediated
signaling has been described (Clark and Brugge, 1995;
Schwartz et al., 1995). By permitting anchorage-indepen-
Figure 8. Treatment of Ras-
expressing cells with the
PI3K inhibitors wortmannin
or LY294002 counteracts the
effects of Ras on the actin cy-
toskeleton. Shown are repre-
sentative fluorescence im-
ages of fibroblasts transiently
expressing Ha-Ras L61. (A)
Ha-Ras L61 alone, or (B) in
the presence of 25 nM wort-
mannin, or (C) in the pres-
ence of 25 mM LY294002. 48 h
posttransfection, cells were
fixed and visualized as de-
scribed in Materials and
Methods. Representative cells
of at least three different ex-
periments are shown for all
panels. Stacks of images
were exported into Adobe
Photoshop and printed as de-
scribed.berall et al. PKC in Ras-mediated Reorganization of Actin Cytoskeleton 423
dent growth, transforming Ras may override the necessity
for cell attachment. Evidence in support of this concept
has been presented (Kang and Krauss, 1996). Both Src and
Ras have been shown to act as important elements in inte-
grin-mediated signaling (Schlaepfer et al., 1998). Expres-
sion of oncogenic mutants of either protein may not only
circumvent integrin receptor activation but may also lead
to a disruption of focal adhesions and stress fibers as a re-
sult of a persistent activation of downstream elements of
the integrin-regulated pathways, as had been suggested for
v-Src (Fincham et al., 1995; Hildebrand et al., 1993).
We are grateful to A. Hall (London, UK), H. Mischak (Berlin, Germany),
and J. Moscat (Madrid, Spain) for providing the plasmid pGST-N17Rac,
pRc-CMV-PKC-l K275W, pCDNA3-PKC-z K275W-HA-tagged, and a
full-length PKC-z cDNA, to S. Geley (Innsbruck, Austria) for subcloning
pEFneoGFP-S65T, and to M. Karin (San Diego, CA) for plasmid pSR-aII
L61 Ha-Ras. Furthermore, the authors wish to thank E. Preuss (Praesen-
tation Dokumentation Lernsysteme, Innsbruck, Austria) for illustration. 
Figure 9. Evidence that
atypical aPKC-l acts up-
stream of PI3K and Rac-1,
whereas aPKC-z functions
downstream of PI3K and
Rac-1. Shown are represen-
tative fluorescence images of
fibroblasts transiently ex-
pressing (CA) atypical
aPKC-l (AÐC). (A) (CA)
aPKC-l alone, or (B) in the
presence of 25 nM wortman-
nin, or (C) 25 mM LY294002;
(D) (CA) aPKC-z A119E
alone, or (E) in the presence
of 25 nM wortmannin, or (F)
25 mM LY294002. 48 h post-
transfection, cells were fixed
and visualized as described in
Materials and Methods. Rep-
resentative cells of at least
three different experiments
are shown for all panels.
Stacks of images were ex-
ported into Adobe Photo-
shop and printed as de-
scribed above.
Figure 10. Quantitative evaluation of total fiber length. Effect of
CA aPKC-l and aPKC-z alone, together with (DN) N17Rac, or
after treatment with the PI3K inhibitors wortmannin and
LY294002. Total F-actin fiber length for all images were calcu-
lated as described in Fig. 4. Shown is a quantitative evaluation of
total F-actin fiber length from fibroblasts expressing CA aPKC-l
and aPKC-z mutants under the influence of (DN) N17 Rac-1, and
the PI3K inhibitors wortmannin and LY294002. Final inhibi-
tor concentrations are described above. Bars indicate means
(6 SEM) of at least three independent experiments with z70Ð75
GFP-positive cells analyzed per coverslip.The Journal of Cell Biology, Volume 144, 1999 424
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